Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Llovet, Laura-Patricia
- Gratacos-Gines, Jordi
- Tellez, Luis
- Gomez-Outomuro, Ana
- Navascues, Carmen A.
- Riveiro-Barciela, Mar
- Vinuesa, Raquel
- Gomez-Camarero, Judith
- Garcia-Retortillo, Montserrat
- Diaz-Fontenla, Fernando
- Salcedo, Magdalena
- Horta, Diana
- Guerrero, Marta
- Rodriguez-Peralvarez, Manuel
- Fernandez-Rodriguez, Conrado
- Albillos, Agustin
- G-Abraldes, Juan
- Pares, Albert
- Londoño MC
Grupos
Abstract
The value of noninvasive tools in the diagnosis of autoimmune hepatitis (AIH)-related cirrhosis and the prediction of clinical outcomes is largely unknown. We sought to evaluate (1) the utility of liver stiffness measurement (LSM) in the diagnosis of cirrhosis and (2) the performance of the Sixth Baveno Consensus on Portal Hypertension (Baveno VI), expanded Baveno VI, and the ANTICIPATE models in predicting the absence of varices needing treatment (VNT). A multicenter cohort of 132 patients with AIH-related cirrhosis was retrospectively analyzed. LSM and endoscopies performed at the time of cirrhosis diagnosis were recorded. Most of the patients were female (66%), with a median age of 54 years. Only 33%-49% of patients had a LSM above the cutoff points described for the diagnosis of AIH-related cirrhosis (12.5, 14, and 16 kPa). Patients with portal hypertension (PHT) had significantly higher LSM than those without PHT (15.7 vs. 11.7 kPa; P = 0.001), but 39%-52% of patients with PHT still had LSM below these limits. The time since AIH diagnosis negatively correlated with LSM, with longer time being significantly associated with a lower proportion of patients with LSM above these cutoffs. VNT was present in 12 endoscopies. The use of the Baveno VI, expanded Baveno VI criteria, and the ANTICIPATE model would have saved 46%-63% of endoscopies, but the latter underpredicted the risk of VNT. Conclusions: LSM cutoff points do not have a good discriminative capacity for the diagnosis of AIH-related cirrhosis, especially long-term after treatment initiation. Noninvasive tools are helpful to triage patients for endoscopy.
© 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of the American Association for the Study of Liver Diseases.
Datos de la publicación
- ISSN/ISSNe:
- 2471-254X, 2471-254X
- Tipo:
- Article
- Páginas:
- 1392-1402
- DOI:
- 10.1002/hep4.1889
- PubMed:
- 34989164
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,757 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Hepatology Communications LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 13
Documentos
- No hay documentos
Filiaciones
Keywords
- ASSESSING LIVER FIBROSIS; ORAL ANTIVIRAL THERAPY; BAVENO VI CRITERIA; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; COMPENSATED CIRRHOSIS; BIOCHEMICAL REMISSION; DIAGNOSIS; VARICES; RISK
Campos de Estudio
Cita
Llovet L,Gratacos J,Tellez L,Gomez A,Navascues CA,Riveiro M,Vinuesa R,Gomez J,Garcia M,Diaz F,Salcedo M,GARCIA M,Horta D,Guerrero M,Rodriguez M,Fernandez C,Albillos A,G J,Pares A,Londoño MC. Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis. Hepatol. Commun. 2022. 6. (6):p. 1392-1402. IF:5,100. (2).
Portal de investigación